In this regard, parkin, a ubiquitin E3 ligase, is reportedly downregulated in AD, inducing Aβ accumulation [217]; parkin treatment or induction of its overexpression has been described as reversing proteasome dysfunction and Aβ accumulation [217,218]. Here, PRKN is linked to Alzheimer disease.